Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.
about
The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammationThe Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer TherapyContribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and AutoimmunityIncreased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy.The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosusIdentification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasisGrowth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure.Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancerVitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activityMerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activityThe expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus.TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.Promising biomarkers for systemic lupus erythematosus.Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker.Increased Mer and Axl receptor tyrosine kinase expression on glomeruli in lupus nephritis.MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.Shedding light on impaired efferocytosis and nonresolving inflammation.Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype.Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction.Antiphospholipid Antibodies Inhibit Trophoblast Toll-like Receptor and Inflammasome Negative Regulators.Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models.Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis
P2860
Q26767123-3620A448-7514-4826-A955-2FC74B6F7D98Q27928010-00915C62-9AF7-419B-B9A8-6334AA56CC36Q28397407-500FA2A7-A7B1-4E23-893C-961726E0165FQ33765614-337AD1C1-635D-4643-9DAE-2C3E5167864BQ34597949-B43B9108-34C4-4B8D-9A77-6685C464BB26Q35426946-48B16BDD-42BB-4A1B-B196-3C1DBCD07FF2Q36340889-597854F2-C9E8-4F24-BD72-401D83BBB67FQ36389223-38229C05-D09C-43DC-B563-2A7511B7A8C0Q36413157-91D2DDB1-2C59-4CDE-B0A5-B5B8115E877FQ36903351-235F9E44-C3C5-48BE-845A-A212BCFAED83Q37183630-C5D2D3C3-7935-4172-8D10-77D30BBDE244Q37690725-E7471541-0816-4EE9-856D-7D1153A94822Q37704582-4BE0A2A3-011A-4521-8EFE-C42A38856A6EQ38105573-7426BA97-46EE-44AB-856A-E512CC8E8D09Q38149960-6E880AF0-5831-4D54-8EEA-550F4F9C019EQ38425946-F91A375B-DBFF-4FBA-81D1-772BAACC7CEBQ38996188-E118160A-2B11-4097-921C-2D0742D2EFA7Q42001768-B251C65B-20A1-4FD2-9260-F125B78D6480Q42965345-7D15CB98-BAF7-4375-B8BF-17F37E703718Q43114569-E5B01312-29C7-4C57-90DB-2BAC420E0DA0Q46346251-58A6C873-A1C2-4CDF-8FE7-1359DC4DC3FBQ48284666-F6A5A0BF-24C7-4971-8F11-E0A1C479C08EQ49998565-56F2EFA9-02C8-463F-BF61-174490CE5EFDQ54225679-05214965-B8AF-4868-BEEF-F928B4D4C3B7Q58601804-283870A8-E09D-430D-AD5D-D22007D2634E
P2860
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased plasma levels of the ...... isease activity and nephritis.
@ast
Increased plasma levels of the ...... isease activity and nephritis.
@en
type
label
Increased plasma levels of the ...... isease activity and nephritis.
@ast
Increased plasma levels of the ...... isease activity and nephritis.
@en
prefLabel
Increased plasma levels of the ...... isease activity and nephritis.
@ast
Increased plasma levels of the ...... isease activity and nephritis.
@en
P2093
P2860
P356
P1476
Increased plasma levels of the ...... isease activity and nephritis.
@en
P2093
Anders A Bengtsson
Anders Gottsäter
Andreas Jönsen
Bengt Lindblad
Björn Dahlbäck
Carl Ekman
Elisabet Lindqvist
Gunnar Sturfelt
Tore Saxne
P2860
P2888
P356
10.1186/AR3316
P577
2011-04-15T00:00:00Z
P5875
P6179
1048003592